Choosing the right bioanalytical CRO partner is one of the most important decisions you’ll make in the development of your drug. For comprehensive characterization that enables you to make your biggest decisions with confidence, go with the pro — Prolytix. Download Now:
High-Resolution Mass Spectrometry + HCP Solutions: The Prolytix Difference Read More »
Picking a partner for your biotherapeutic program is one of the most crucial decisions you’ll make. When you partner with a CRO, you’re melding outside expertise and resources with your internal knowledge base to expand and accelerate your problem-solving capabilities. This is a tremendous gain, but it’s important to remember that you are the client,
Choosing the appropriate analytical and bioanalytical CRO partner is critical to the success of your biotherapeutic drug development program. Selecting the wrong partner could delay timelines and increase costs, putting your innovation at risk. For large molecule and protein chemistry expertise to accelerate your drug development, go with the pro — Prolytix. Download Now:
Process Development, Analytical Development, & GMP Testing and Release Services Read More »
Explore our work with a highly efficient method of plasma fractionation that could revolutionize IVIG production in this process talk by Matthew Whelihan, Ph.D. Download Now:
Using mass spectrometry to identify and quantify HCPs enables a more rational development of robust purification processes.
The Vanderlaan et al. article published in 2018 is still one of the best summaries of biopharma’s experience with Host Cell Proteins (HCPs).
A highly efficient method of plasma fractionation that has the potential to address the growing global IG product shortage. Read the Case Study Now:
